##
##
|Trustees|||Professor Michael|Professor Michael|Milward|President|2023|2023|||
|---|---|---|---|---|---|---|---|---|---|---|
||||Dr Ra/an
Nansi|||President|2022||||
||||Professor Mark|Ide||Immediate||Past President|Resigned|31 December 2022|
||||Professor Wendy Turner|||Honorary|Secretary||||
||||Dr lan Dunn|||Honorary|Treasurer||||
||||Professor
Philip|Preshaw||President|Elect 2024||Appointed|1 January 2023|
||||Professor Nicola West|||President|Elect 2025||||
||||Professor Francis Hughes|||Senior Vice||President|Resigned|31 December 2022|
||||Professor Gerry|Linden||Senior Vice||President|Appointed|1 January 2023|
||||Dr Alexander
Pollard|||Honorary|Editor||||
||||Dr Viren Vithlani|||Commercial||Liaison Officer|||
|Charity|number||265815||||||||
|Princl pa|I address||P0 Box261||||||||
||||Liverpool||||||||
||||L25 6WP||||||||
|Independent||examiner|Alison Whalley|FCA|||||||
||||Azets||||||||
||||Carlton House||||||||
||||Bradford||||||||
||||BD1 4NS||||||||
|Bankers|||CAF Bank Ltd||||||||
||||25 Kings
Hill Avenue||||||||
||||Kings
Hill||||||||
||||West Mailling||||||||
||||Kent||||||||
||||ME194JQ||||||||
||||Bank ofScotland||||||||
||||33 Old Broad Street||||||||
||||London||||||||
||||BX2 1LB||||||||
##
||||Page|
|---|---|---|---|
|Trustees
report|||1-9|
|Independent
examiner's||report|10|
|Statement
of financial|activities|||
|Balance sheet|||12|
|Notes to the accounts|||13-23|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||||||PRIZE|||Award|
|---|---|---|---|---|---|---|---|---|---|---|---|
|Audit award||||||||||||
||||||||||||F500|
|No award||||||||||||
|Sir Wilfred Fish||Research|||Prize|||||||
|Vitor Neves|||||||||||E1,000|
|"Glucose metabolism
medicine. "|||modulation|||in periodontal||disease prevention||as a form ofpreventive||
|S stematic|Review Prize|||||||||||
|Varkha
Rattu|||||||||||E1,000|
|"Prevalence|ofstable||and||successfully||treated|periodontitis|subjects and incidence ofsubsequent
"|||
|tooth loss within||supportive|||periodontal||care: A systematic||review and meta-analyses.|||
|BSPClinical|Fellowshl|||award|||||||Up to E4,000|
|Hong Jin Tan|||||||||||per award|
|Frank Ashle|Under||raduate|||Prize||||||
||||||||||||E500|
|Kate McNelly||||||||||||
|BSPResearch Grant|||||||||||Up to F5,000|
|Joshua Jackson|||||||||||per award|
|Poster Prize||||||||||||
|Clinical:||||||||||||
|Chaitanya
Joshi|||||||||||f500 each|
|Research:||||||||||||
|Annabel
Simpson||||||||||||
##
##
|Date|Type of
Event|Title|Presenter|
|---|---|---|---|
|||Time to take periodontitis
seriously: economic &societal||
|20 Jan|Webinar|costs and how to implement
the steps ofcare in real|Prof lain Chapple|
|||world NHS practice||
|||Avoidance
of Doubt - the S3guidelines
and phased||
|10Feb|Webinar|treatment
approach
to periodontal
care within the NHS|Dr Shazad Saleem|
|||dental contract||
|10 Mar|Webinar|Approaching/implementing
behaviour
change
in treating
periodontal
disease
in practice|Dr Christoph
Ramseier|
|26 Apr|Webinar|Management
of peri-implantitis
a pragmatic
approach|Prof Andreas
Stavropoulos|
|17 May|Webinar|Pre-prosthetic
surgery
- Enabling
optimal
restorations|Prof Moritz Kebschull|
|||Minimally
invasive
non-surgical
periodontal
therapy||
|9 Jun|Webinar|practical approaches
and protocols to ultrasonic|Dr Devan
Raindi|
|||debridement||
|22nd Jun|Masterclass|Peri-Implantitis
Masterclass —Diagnosis and Treatment
Modalities|Prof Nikos Donos|
|12Jul|Webinar|Instrumentation
selection and advanced
techniques
for
sub gingival
PMPR|Ms Claire McCarthy|
|13-15hOct|Conference|BSPConference 2022|Dr Rajah Nansi|
|1 Nov|Webinar|Supportive
Periodontal
Care
—Practical
implementation
ofstep 4 of the S3guidelines|Dr Viren Vithlani|
|16 Nov|Webinar|The Bernese Concept for the Treatment
of Single and
Multiple
Mandibular
Recessions|Prof Anton Sculean|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|
|||funds|funds||funds|funds||
|||2022|2022||2021|2021|2021|
||Notes|6|6||f|8|6|
|Income from:||||||||
|Donations
and legacies|3|1,000||1,000|1,000|6,000|7,000|
|Charitable
activities|4|366,919|85,000|451,919|394,626|50,000|444,626|
|Investments|5|3,361||3,361|861||861|
|Total income||371,280|85,000|456,280|396,487|56,000|452,487|
|~E«dlt||||||||
|Charitable
activities|6|319,305|32,587|351,892|324,490|33,737|358,227|
|Net Income for the year/||||||||
|Net movement
ln funds||51,975|52,413|104,388|71,997|22,263|94,260|
|Fund balances at 1||||||||
|January 2022||561,065|75,895|636,960|489,068|53,632|542,700|
|Fund balances at 31||||||||
|December 2022||613,040|128,308|741,348|561,065|75,895|636,960|
##
##
##
||||||2022||2021||
|---|---|---|---|---|---|---|---|---|
|||||Notes|6||8||
|Fixed assets|||||||||
|Tangible assets||||||705|||
|Current assets|||||||||
|Debtors||||12|35,236||28,048||
|Cash at bank and|in|hand|||736,832||660,528||
||||||772,068||688,576||
|Creditors: amounts||falling|due within||||||
|one year||||13|(31,425)||(51,616)||
|Net current assets||||||740,643||636,960|
|Total assets less|current||liabilities|||741,348||636,960|
|Income funds|||||||||
|Restricted funds||||15||128,308||75,895|
|Unrestricted
funds|||||||||
|Designated
funds||||16|371,920||371,825||
|General
unrestricted||funds|||241,120||189,240||
|||||||613,040||561,065|
|||||||741,348||636,960|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Charitable|Charitable|
|---|---|---|---|
|||Income|Income|
|||2022|2021|
|||8|6|
|Subscriptions||201,535|195,617|
|Partnership|agreements|85,OOO|50,000|
|Conferences||144,064|189,425|
|Educational|courses and webinars|18,000|6,530|
|Leaflet sales||3,320|3,054|
|||451,919|444,626|
|Analysis
by fund||||
|Unrestricted|funds|366,919|394,626|
|Restricted|funds|85,000|50,000|
|||451,919|444,626|
##
|||Unrestricted|Unrestricted|
|---|---|---|---|
|||funds|funds|
|||2022|2021|
|||6|6|
|Interest|receivable|3,361|861|
##
##
##
|||2022|2021|
|---|---|---|---|
|||6|6|
|Journal - paper||9,512|10,729|
|Journal
- electronic||37,519|39,085|
|Conference costs||89,143|149,464|
|Event management|fees|32,817|23,907|
|Awards
and prizes||12,331|10,682|
|Educational
initiative||26,265|33,737|
|Educational
courses|and webinars|19,793|9,042|
|BSPEvents/Non
BSPEvents||7,314||
|Donations
and sponsorship||1,030||
|||235,724|276,646|
|Share ofsupport costs (see note 7)||105,600|76,50e|
|Share of governance|costs (see note 7)|10,568|5,073|
|||351,892|358,227|
|Analysis
by fund||||
|Unrestricted
funds||319,305|324,490|
|Restricted
funds||32,587|33,737|
|||351,892|358,227|
##
##
##
|7|Supportcosts||||||||
|---|---|---|---|---|---|---|---|---|
||||Support|Governance|2022|Support|Governance|2021|
||||costs|costs||costs|costs||
||||f|f||6|f||
||Depreciation||503||503||||
||Legal fees||1,056||1,056||||
||Admin
travel||268||268|110||110|
||Business Management||||||||
||fees||54,402||54,402|44,358||44,358|
||Office costs||13,939||13,939|9,347||9,347|
||Insurance||668||668|610||610|
||Sundry||562||562|1,001||1,001|
||Irrecoverable
VAT||25,209||25,209|13,583||13,583|
||Computer
and|website|2,801||2,801|2,012||2,012|
||Worldpay
and|Bank|||||||
||charges||5,343||5,343|2,178||2,178|
||Accountancy||849||849|3,309||3,309|
||Cost oftrustees|meetings||525|525||41|41|
||Independent
examination|||4,500|4,500||4,500|4,500|
||Indemnity
insurance|||881|881||456|456|
||Trustees and council||||||||
||members
expenses|||4,662|4,662||76|76|
||||105,600|10,568|116,168|76,508|5,073|81,581|
||Analysed
between||||||||
||Charitable
activities||105,600|10,568|116,168|76,508|5,073|81,581|
##
##
##
##
##
|11|Tangible fixed assets|Tangible fixed assets|Tangible fixed assets||||
|---|---|---|---|---|---|---|
||||||Fixtures and fittings||
|||||||6|
||Cost||||||
||At 1 January|2022||||4,250|
||Additions|||||1,208|
||At 31 December 2022|||||5,458|
||Depreciation|and Impairment|||||
||At 1 January|2022||||4,250|
||Depreciation|charged|in the year|||503|
||At 31 December 2022|||||4,753|
||Carrying
amount||||||
||At 31 December 2022|||||705|
|12|Debtors||||||
||||||2022|2021|
||Amounts
falling due||within one year:||8|8|
||Trade debtors|||||24,000|
||Other debtors||||1,817|1,608|
||Prepayments|and accrued income|||33,419|2,440|
||||||35,236|28,048|
|13|Creditors: amounts||falling due within one year||||
||||||2022|2021|
|||||Notes|6|f|
||Deferred income|||14|21,560|33,027|
||Trade creditors||||5,115|5,255|
||Accruals||||4,750|13,334|
||||||31,425|51,616|
##
##
||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|
||||||||E|E|
|Other deferred||income|||||21,560|33,027|
|Deferred|income||is included|in the financial|statements|as follows:|||
||||||||2022|2021|
||||||||E|E|
|Brought|forward||||||33,027|178,135|
|Amount|released||to income||||(33,027)|(175,316)|
|Amount|deferred||in year||||21,560|33,027|
|Refunded||||||||(2,819)|
|Carried|forward||||||21,560|33,027|
##
|||||Movement|in funds|||Movement|in funds||
|---|---|---|---|---|---|---|---|---|---|---|
|||Balance at||Incoming|Resources|Balance at||Incoming|Resources|Balance at|
||1|January|2021|resources|expended1|January|2022|resources|expended|31 December|
|||||||||||2022|
||||||E||F|E|E|E|
|Partnership|||||||||||
|Agreements||53,632||50,000|(33,737)|69,895||85,000|(32,337)|122,558|
|Patient|||||||||||
|Forum||||6,000|||6,000||(250)|5,750|
|||53,632||56,000|(33,737)|75,895||85,000|(32,587)|128,308|
##
##
##
|||Balance at|Transfers|Balance at|Transfers|Balance at|
|---|---|---|---|---|---|---|
|||1 January
2021||1 January
2022||31 December|
|||||||2022|
||||||E|E|
|Contingency|Fund|141,670|284|141,954|95|142,049|
|EP8 2015 Legacy||175,000||175,000||175,000|
|EP9 2018 Legacy||54,871||54,871||54,871|
|||371,541|284|371,825|95|371,920|
##
|Funds||||||||
|---|---|---|---|---|---|---|---|
||||Balance at1|Income|Expenditure|Transfers|Balance at 31|
||||January
2022||||December|
||||||||2022|
||||E|E|E|E|E|
|Restricted||funds|75,895|85,000|(32,587)||128,308|
|Designated||funds|371,825|||95|371,920|
|General|funds||189,240|371,280|(319,305)|(95)|241,120|
||||636,960|456,280|(351,892)||741,348|
|Funds|prior year|||||||
||||Balance at 1|Income|Expenditure|Transfers|Balance at 31|
||||January
2021||||December|
||||||||2021|
||||E|E|E|E|E|
|Restricted||funds|53,632|56,000|(33,737)||75,895|
|Designated||funds|371,541|||284|371,825|
|General|funds||117,527|396,487|(324,490)|(284)|189,240|
||||542,700|452,487|(358,227)||636,960|
|||||m
0|DI
O|4I||||O
(D
CD|O
(D
Ot|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||(D
CO
(D|CD
(O
(D|
|||||lD||4l||||ID|ID|
|||||m|0|||||OI
CO|CO|
||||||OI|||||||
|||||DI||||||||
|||||ID0t||||||CO|CO|
|||||CI||||||||
|||||l3
8
0|CII0
OI|4(||||||
|||||N||||||||
|||||m||||||||
|||||m
m|CV
o|||||O|O|
|||||Ct(3||||||CD
CO|Ot
CO|
|||||||4l||||||
|I-||||D
t-|CV
O
Ol|||||O||
|MI-Z
CII-||||00
m
C
00|Ol
olO
OI|4l||||O
Dt
I(O|O
Dt
CO|
|||||III||||||||
|||||Ct||||||||
|||||CI||||||||
|||||D
(D
0|OI
CVO
Ol|4l||||CO
O
CO|CO
O
CO
CO|
|||||+||||||Dt||
|||||Dt||||||||
|CIZ||||Ct
It"||||||||
|00
0I-Z0
CI0|CI
UJDZI-z0
O
V)I-Z
UJ|UI||m
C
CtG|Ol
O
Ol|4l|||ID
O|ID
O|O
PI|
|||Kl||||||||||
||UJ||||||m|||||
|0|I-c(
M|O
LLI
CI|Dt
'O
C
C
Ct||||(0
CI|||||
||||||||Cl|||||
||||||||Xl|||||
|O0
V)z
V)I-
Kl
ZI-|OZ
z
UJZI-0I-
N
UJI-0z|UI
CI
CI
UJ|8
(A
lft
Ol
(DCID
Ilt
(0C||||E
Ct0
tDD
(0
N0t
0
C
t0
Ol
l3
C|Cl
lD
Ct
C(0
tfl
S
Ot|fD
Ct
g
(0
'at
Ot
Im|(0
ID
Zlt0
N
S
(0
C
m
0||
#